Drugs Health Medical Pharma

Novartis’ Kisqali shows 25% reduction in breast cancer recurrence

HQ Team June 3, 2023: Novartis breast cancer drug Kisqali cut the risk of recurrence of the disease by more than 25% in.

Read More
X